“Now that the MBO seems likely to move forward, I thought it was time for me to set down the philosophy which will underlie ownership of CDC. (1) The objective in buying CDC in the first place is to secure for those who work there, all of the carried interest and all of the annual cashflow surplus generated by CDC. Other than as contemplated in (3) below, it is not intended that there be any other economic benefit flowing from the ownership of CDC. No dividends, for example, are likely to be paid. (2) Ownership would not confer any right to participate in or alter the management of CDC. Any changes to the way in which CDC is being managed or, indeed, to the people who manage the firm would be dealt with by the management for the time being. A shareholding as such would give the shareholder no rights in that regard. Thus, if a shareholding held today was passed on, for example by way of inheritance, to another party, that party would have no rights whatsoever either to money or influence, other than as provided in (3) below. (3) It is possible that CDC, in the medium or longer term, could acquire a value. At the moment, and as we have just seen, it has little value other than in the hands of those who run it. However, it is possible that it could acquire a value, over time, as a fund management business which could be sold in whole or in part for a substantial goodwill figure. That is the reason why I am anxious to protect CDC's new shareholders from being forced prematurely to sell out in the future; recognising that, through clause (2) above, all management control will reside in the hands of the management for the time being and that no limitation is placed on that by any non-management shareholders. My idea is that there be no pre-ordained arrangements or formula which would govern transfers of shares. On the other hand, if there was an offer for any or all of the CDC share capital there would be appropriate tag and drag along provisions.”
“. . . . There are a number of views on this, as you may imagine, but the common ground is as follows. The absolute intention is to maximise the value of CDC to the people who are there today. In other words, no one is particularly concerned with the financial well being of those who will succeed us at CDC. Taking this as the overall objective there are, for the time being, two broad schools of thought. The first takes the view that there is no goodwill in CDC as such or at any rate very little, as evidenced by our most recent discussions with HSBC. The goodwill, if any, of CDC resides only in the people running it for the time being. The argument then is that the right course for the people currently at CDC is to ensure that all of the cash generated by the company should be paid out year by year. The cash which CDC generates comes from management fees and carried interest. Carried interest is straightforward, since it is allocated to individuals, essentially in full, when each fund is raised. Where the cash flow generated by management fees is concerned, those who belong to this school of thought would argue that it should be paid out fully, subject to an obvious hold back for prudence, as salary and bonuses each year. None would, in other words be retained within the firm to build goodwill since it is accepted that the firm will not have any goodwill. All power under this argument is vested in the managers of the business through whatever documentation is necessary (presumably the Shareholders Agreement and Articles of Association). Shareholders have essentially no power but if, in the unlikely circumstances of CDC having some goodwill, the original shareholders get the benefit (if say, CDC is sold). From this it follows that no formal arrangements need to be made in advance to cover future transfer of shares since in themselves the shares offer no economic benefit; and it is appropriate for future transfers to be dealt with as people see fit at the time. Share ownership in these circumstances could, in John Major's words, cascade down the generations. The other school of thought, whilst not disagreeing with the objectives set out above, argues that, although today we may see no prospect of CDC as such having any goodwill, to organise affairs as described above guarantees that CDC will not accumulate goodwill. Future managers may receive the cashflow benefits which the firm generates, but if they have no share ownership of CDC they will not take the business forward (for example as a growing fund management business) if they have no ownership incentive to do so. It therefore makes sense to provide now for the future transfer of at least some proportion of the CDC share capital to its future managers on some basis. In support of that view, they also raise the question of whether it is realistic (or even legally feasible) for there to be, in future, a group of ageing or perhaps dead shareholders whose shares confer no rights in the way described above. They also take the view that now is the time to resolve any such questions since today we are talking amongst colleagues and friends where there is no current divergence of interests, which may become less true as time passes.”
“I have read Alastair’s discussion paper and it confirms my previous opinion that trying to legislate now for a price in say ten years time is impractical. The “devil is in the detail.”
“FUNDAMENTAL ASSUMPTIONS & PRACTICES FROM WHICH A SHAREHOLDERS AGREEMENT WILL BE DERIVED 1. The Founders (i.e. original shareholders) wish to maximize the value of their investments in CDC within a [eight] year timescale. 2. In the absence of an agreed alternative strategy (e.g. invest in starting up a CDO or technology fund) the Founders intend to strip CDC of cash each year subject to • Borrowing • CDC’s typically prudent accounting policies • assumption 1. above. . . . . . 9. In the event that CDC is not sold after eight years, the Company will no longer be stripped of cash through paying “excessive” bonuses. Instead the cash will be paid out by way of dividends.”
“ . . . We understand that, in order to reflect the new proposal, we will need to provide for all remuneration decisions (i.e. salary reviews, salaries to be paid to new employees, bonuses, carried interest entitlement and any other discretionary payments) to be made by Gordon in his sole discretion. We assume that, once Gordon ceases to be chief executive (regardless of whether or not he remains a shareholder) the remainder committee (constituted as per the existing provisions in the Shareholders Agreement) will be responsible for making all remuneration decisions.”
“The LLP shall be under no obligation to make a distribution of profits in any circumstances. The Managing Member shall determine in its sole discretion whether a distribution of profits is to be made, how much of the Profits are available for distribution and to what extent a distribution of such amounts shall be made.”
“11.3 The Remuneration Committee shall make determinations on all matters concerning the emoluments payable or proposed to be paid to any employee or director of the Company or other member of the Group (including, without limitation, initial salary, salary reviews and the setting of bonus levels and performance targets, co-investment opportunities and entitlement to carried interests) and shall be empowered, on behalf of the Company (but not on behalf of the relevant employee or director) to amend any of the terms of the service contracts of any such employee or director from time to time. Any determinations on matters relating to the allocation of profits of the LLP which are to be made by Charterhouse Development Capital Limited pursuant to the terms of the LLP Deed shall be made by Charterhouse Development Capital Limited acting through the Remuneration Committee. The parties hereto shall procure, so far as they are able, that such determinations are implemented by the LLP and any member of the Group which is a Member of the LLP.”
“I can see the agreement being similar to the one entered into with Simon Drury back in 2004, specifically: 1. Geoff will get six months of scheduled monthly drawings up to 30 June on the 31 December level but no bonus drawings. 2. His carry in the VIIIth fund will vest (earlier funds are already vested) and he will keep any co-investment he already has and co-investment in any new deals done up to 30th June will be funded by special drawings. 3. I think we will offer him the chance to co-invest in any other CCPVIII deals after 30th June but he will have to pay for them himself and if he turns one down he loses the option.”
“2 It is acknowledged that you hold 900 A Ordinary Shares in the capital of Charterhouse Capital Limited (the Shares) and that nothing in this Agreement (including but not limited to Clause 19) shall affect your rights in relation to the Shares.”
“Nothing of great significance to report – Geoff said that both he and Trevor felt it was a fair agreement.”
“Retiring partners I don't know what thoughts you have regarding Geoff’s position and whether you want to discuss this. It does occur to me that there are now a number of partners in various "transition' states (Geoff, Tom, Simon, me and possibly Duncan and Edward) and between us we have about one-third of the Charterhouse shares. Next year might be an opportunity to consider a reorganisation, perhaps after CCPIX [Fund IX] has been raised.”
“I would rather cancel our lunch tomorrow but would like to meet with you and Edward Cox before July is out and before Fund 9 is closed. Can you arrange that for the w/b 21 July? . . . It is in everyone's best interests if we keep this meeting to ourselves. . .”
“As the second largest shareholder in Charterhouse and as someone who worked there for 24 years I am astonished that the Chairman refuses to meet me for a confidential meeting and that you feel it necessary to inform Gordon despite my request that you do not. I suggest you reconsider on both counts. When can you both make it. I believe that it is in everyone's best interests if we have that meeting before Fund 9 closes.”
“O/Clean Break KPMG [???] Def[f]erred 2 stage process JGB reneged Would not have signed resignation HS ‘strong case’ • Misrepresentation • Collateral Agreement • Unfair Prejudice Confidentiality Breaches Plundering corporate data 18 months / “Background to Deal”
“a number of matters, (first) your shares in Charterhouse and what you saw as Charterhouse's commitment to acquire these, (second) what you suggested were unlawful activities carried out by Charterhouse and (third) the link you made between these two matters.”
“You informed me that you only signed your resignation on the understanding that this should be linked to a process which would result in the sale of your shares. I was aware of no such assurance and, while Gordon acknowledges that he did discuss with you the possibility of obtaining a valuation, no agreement was reached, not least because of your own very unrealistic expectations as to value. You had your own legal advice at the time and I am advised that the agreement deals with your shares at your request by containing only acknowledgment as to your title and ownership. You sought no reference to a sale process.”
“. . . In drafting these minutes, I have formed the view that the independent directors should not, as directors, hold themselves out as negotiating with Newco on terms for recommendation to the shareholders. The normal considerations in a public takeover are not relevant here, and so the Company's role (and so the role of the directors) should only be to ensure compliance with the various obligations to which it is subject. To the extent that the independent directors wish to enter into negotiations on terms, they should do so as shareholders. You will appreciate this is to ensure that neither the Company nor the directors (in that capacity) incur any liability to shareholders in relation to the terms of the acquisition . .”
“The Board of Directors of Charterhouse Capital Limited (the “Company”) is aware that discussions have for some time been taking place regarding a possible reorganisation of the Company and its subsidiaries with a view to securing the future success of the Company and its subsidiaries and maintaining the best possible relationship with investors in the Charterhouse funds. The Board has been informed that certain of the Directors wished to present a possible reorganisation (their “Proposal”) but the Board has been advised that doing so may put them in a situation in which they have, or could have, a direct or indirect interest that conflicts, or possibly may conflict, with the interests of the Company. To enable the relevant Directors to develop and present their Proposal without risk of infringement of this duty [conflicts of interest with the Company], certain of the Company's members have proposed that members give the Directors the power to authorise matters giving rise to a conflict of interest. The power being sought is a general power which will enable the Directors to authorise any such matters after the time at which it is passed. A written resolution granting the power referred to above is enclosed. In order to vote in favour of the resolution, please sign and date it, and send it as soon as possible . . . .”
“5. Circulation of Written Resolution ... The Chairman adjourned the Meeting while the resolution was sent or submitted to the members for their approval and signature. It was noted that the resolution was to be despatched immediately by email, and sent by first class post, to all members. 6. Authorisation of Conflict of Interests 6.1 When the Meeting was reconvened by the Chairman, he informed the Meeting that the resolution had been duly passed as an ordinary resolution. 6.2 The Chairman then proposed that the Board proceed to consider a resolution of the Directors, as now permitted in accordance with the ordinary resolution, to authorise certain matters which would or might constitute a conflict of interests for the Continuing Directors in accordance with the statutory power set out inSection 175(5)(a) of the Companies Act 2006 . ... 6.6 The Retiring Directors considered the matters set out in this paragraph 6 and IT WAS UNANIMOUSLY RESOLVED by the Retiring Directors THAT: 6.6.1 it would be in the interests of the Company for the shareholders to have an opportunity to receive and consider the Proposal and therefore to facilitate the development by the Continuing Directors of the Proposal which they had been considering and consequently the Retiring Directors should take the necessary steps to authorise the potential conflicts of interests that had been identified; 6.6.2 those matters referred to in 6.3 above, being matters which would or might conflict with the interests of the Company, be and are hereby authorised in accordanceSection 175(5)(a) of the Companies Act 2006 ; and 6.6.3 in their respective capacities as directors of the Company, the Continuing Directors take no part in any discussion and decisions involving the Company which relate directly or indirectly to the Proposal, and in particular do not attend any Board meeting (or part of a Board meeting) at which such matters are under consideration, and receive no information from the Company or the Board relating to the Company’s involvement in the Proposal or the Board’s consideration of such matters. 7. Appointment of Shepherd and Wedderburn The Chairman explained that that it was considered necessary for the Company to receive independent advice in relation to the Proposal and any implementation thereof. It was noted that Shepherd Wedderburn LLP had been instructed to provide advice to the Company, represented by the Retiring Directors for such purposes, and IT WAS RESOLVED THAT such appointment be approved and ratified and that any of the Retiring Directors be authorised to agree and sign an engagement letter from Shepherd and Wedderburn LLP in respect of the appointment.” ... The Chairman adjourned the Meeting while the resolution was sent or submitted to the members for their approval and signature. It was noted that the resolution was to be despatched immediately by email, and sent by first class post, to all members. ... 6.6.1 it would be in the interests of the Company for the shareholders to have an opportunity to receive and consider the Proposal and therefore to facilitate the development by the Continuing Directors of the Proposal which they had been considering and consequently the Retiring Directors should take the necessary steps to authorise the potential conflicts of interests that had been identified; 6.6.2 those matters referred to in 6.3 above, being matters which would or might conflict with the interests of the Company, be and are hereby authorised in accordanceSection 175(5)(a) of the Companies Act 2006 ; and 6.6.3 in their respective capacities as directors of the Company, the Continuing Directors take no part in any discussion and decisions involving the Company which relate directly or indirectly to the Proposal, and in particular do not attend any Board meeting (or part of a Board meeting) at which such matters are under consideration, and receive no information from the Company or the Board relating to the Company’s involvement in the Proposal or the Board’s consideration of such matters. The Chairman explained that that it was considered necessary for the Company to receive independent advice in relation to the Proposal and any implementation thereof. It was noted that Shepherd Wedderburn LLP had been instructed to provide advice to the Company, represented by the Retiring Directors for such purposes, and IT WAS RESOLVED THAT such appointment be approved and ratified and that any of the Retiring Directors be authorised to agree and sign an engagement letter from Shepherd and Wedderburn LLP in respect of the appointment.”
“Dear Edward 1. Thank you for your quick reply of27 October 2011 by email and for the new information. Subject to receiving answers to the queries in this paragraph and an assurance that in future the Board of CCL will immediately bring any future conflicts of interest to the attention of shareholders I agree to support the written resolution and to sign and post it to Linda. - How long have you been aware of this conflict? - Why is the Continuing shareholders Proposal so vague? I presume a buyout is envisaged as it is not obvious to me how else you align “......ownership of the General Partner.....to those who conduct the investment business”
“. . . My primary role at this point, as elected Chairman of a Board meeting held on 21 October, was to ensure that the shareholders were appropriately notified of the resolution then proposed and, subject to the passing of that resolution, to invite the Board to authorise the conflict of interests that had been identified - which it has now done, enabling the “Continuing shareholders” to work up their proposal. As you have already been informed, we have appointed lawyers to act for CCL [the Company] to ensure that the Board is appropriately advised in relation to the matters arising from the proposal anticipated (but not yet received) from the Continuing shareholders. Please note that these lawyers are acting for CCL [the Company] itself not any shareholder(s) individually or collectively and the appointment was therefore properly the province of the Board. Since you ask about timing, I am aware that the Continuing shareholders’ proposal is still being worked on and I understand that they wish to present it as soon as possible to all shareholders at the same time - and of course on the same terms. . .”
“ . . . almost entirely on subjective judgements about: 1. The level of bonuses required to retain and motivate the investment team. This must be viewed in the context of the key man clauses and the reliance of the firm's future income streams on the continuing participation of these individuals; and 2. The prospects for raising a successor fund to CCP 9 [Fund IX]. This must be heavily discounted at present as there have been no exits in CCP 8 or 9 [Fund VIII or IX] and the succession plan still has to be demonstrated as robust. Similarly, without the support of the investment team we cannot solicit or develop an alternative competing offer. So given the circumstances, any valuation is essentially a goodwill payment to reflect the value of the brand and ensure the interests of the investors in the fund are protected. The response from the team to Geoff’s attempt to put forward a competing offer should be formally documented even if the SPA is now effective.”
“4.1 The sale and purchase of the Sale Shares pursuant to this Agreement are in all respects conditional upon: 4.1.1 the FSA, in respect of the Purchaser and each controller of the Purchaser, either (a) giving notice under section 189(4)(a) of FSMA . . . . . 4.1.2 a Founder Special Majority (as defined in the Shareholders’ Agreement) consenting for all purposes under the Shareholders’ Agreement to the transactions contemplated by this Agreement; 4.1.3. the Amended Articles being adopted by the Company as its articles of association; 4.1.4 a Founder Majority (as defined in the Amended Articles) approving the sale and purchase of the Sale Shares pursuant to this Agreement as a Relevant Sale (as defined in the Amended Articles) for the purpose of article 39 of the Amended Articles; and 4.1.5. the Purchaser’s desire to acquire the entire issued share capital of the Company in the manner contemplated hereby being approved at a meeting to which all Non-Concert Members are invited, by Non-Concert Members (a) representing a majority number of all Non-Concert Members in attendance at that meeting, and (b) holding in aggregate at least two thirds of the Shares held by all Non-Concert Members in attendance at that meeting. 4.2 For the avoidance of doubt, the Purchaser has no desire to purchase, and the Vendors have no desire to sell, the Sale Shares unless and until each of the Conditions is fulfilled.”
“A P/E ratio is a measure of the price per share relative to the annual net income or after tax profit earned by the company per share. A P/E ratio approach involves applying appropriate P/E Ratios to the historical, current and/or forecast earnings of a company. P/E Ratios are derived from comparable, listed companies and may be adjusted to reflect such factors as size, or range of activities. P/E Ratios may also be observed where there is a transaction in private companies. The value resulting from applying an appropriate P/E Ratio to profit after tax is the market capitalisation or equity value, and represents the value of the company to equity shareholders.”
“If there had been a steady income stream then it would have lent itself much more to applying a crosscheck with a multiples approach, yes, but I would have needed to find the appropriate companies. My challenge here is not so much one of methodology, it is one of finding the appropriate comparables and making the right adjustments to those.”
“…. you have to have good comparable companies otherwise you are not in the same risk and growth profiles. The next problem and why, as I said yesterday I think, that I dislike the AUM approach, if you don't adjust for margins, ie the profit you would generate, it is far too crude because a loss-making AUM business would have the same value as a profitable one, so you have to -- you know when you see that if you look at -- if you are valuing a profitable -- highly profitable AUM business and it has a percentage of funds under management and then you were to look at a loss-making one, you can't simply apply the same percentage of funds under management. That would be ridiculous. You would get the same value for the loss-making company, because it has got the same amount of funds under management, as the profitable one. You have to understand what's driving the profits and that's why I believe this is such a crude and unhelpful approach, particularly when the heart of the dispute here revolves around a remuneration model which impacts directly the margin on the business. So by simply taking a group of comparable companies and taking a percentage of their funds under management and saying "This gives me a value" misses out the whole point of the dispute before the court, as far as I can see. That's why I found it particularly unhelpful despite all the other technical limitations to the approach.”
“ . . . if you were going to start with Intermediate Capital and 3i, KKR and Blackstone, it is obvious to me that there are far too many adjustments to give you a reliable benchmark. You have got a very different business model, single sequential funds, you have got very different size, you have got assets on the balance sheet. Even if you split out the asset management companies you have very different activities within the asset management companies. You have different growth prospects. By the time you make all the subjective adjustments for those factors I'm not sure you would ever get any real comfort around the value from that methodology, which is why -- which is not my preferred approach -- I only used one methodology. I would always prefer to use more than one methodology and it is when you look at the answers that you get when you use those approaches, it challenges you to look at your discounted cashflow again and say "Where could I have gone wrong?" and you cannot bridge the gap because you are comparing, in my view, absolutely apples and pears when you look at these companies as a whole.”
“The hypothetical purchaser and vendor are as you say anonymous, but the investment team is not anonymous, so the market value is, as I explained, trying to get to the real world value and the real world value will be looking at what's the risk associated with the management team on a transfer of ownership of them staying with the company, or indeed any change in any remuneration structure for example which is one of the ways in which you could extract money out of the company. So to that extent it was necessary to consider what the risks were associated with the investment team and the lack of alignment. So if you look at it from the point of view of the buyer, the buyer would be concerned, if there was a lack of alignment, because the investment team might walk. It is a risk factor for the buyer.”
“…to isolate the value attaching to the shares rather than any value that might be attributable to the management team beyond their contractual obligations”
“ -- if you imagine going back to the real world, that -- and I think this is the danger of mixing hypothetical with -- but if you go back to the real world and the management team were intending to sell the on the 11th, I would presume some time prior to the 11th they would have distributed to themselves any surplus cash. So I think -- I don't think it is an unreasonable assumption. I can see it depends precisely when you decide you kick in the hypothetical basis of valuation, pre-or post where you distribute the earnings, but that's what the instructions quite clearly say.”
“A member of a company may apply to the court by petition for an order under this Part on the ground- (a) that the company’s affairs are being or have been conducted in a manner that is unfairly prejudicial to the interests of members generally or of some part of its members (including at least himself), or (b) that an actual or proposed act or omission of the company (including an act or omission on its behalf) is or would be so prejudicial.”
“the section is not directed to the activities of the shareholders amongst themselves, unless those activities translated into acts or omissions of the company or the conduct of its affairs.”
“ . . .Conduct of anyone involved in a company may be so far removed from actually carrying on the affairs of the company that it does not amount to the conduct of the company’s affairs for the purposes of s994. But in my view, s 994 is concerned with the practical reality which obtains on the ground in relation to the conduct of a company’s affairs, and there is no sound reason to exclude the possibility that what someone does in exercising or purporting to exercise managerial power as a director or senior employee should not in principle qualify as conduct of the affairs of the company for the purposes of that provision.”
“ . . . a member of a company will not ordinarily be entitled to complain of unfairness unless there has been some breach of the terms on which he agreed that the affairs of the company should be conducted. But the second leads to the conclusion that there will be cases in which equitable considerations make it unfair for those conducting the affairs of the company to rely upon their strict legal powers. Thus unfairness may consist in a breach of the rules or in using the rules in a manner which equity would regard as contrary to good faith.”
“The question whether any action was or would be 'unfairly prejudicial' to the interests of the members has to be judged on an objective basis. Accordingly it has to be determined, on an objective basis, first whether the action of which complaint is made is prejudicial to members' interests and secondly whether it is unfairly so.”
“ . . . the growth policy was adopted and acquiesced in at a time when Ms Kohli was a director. In that respect, the normal expectation of shareholders was abrogated or qualified.”
“A share is a right of property, and the right of a shareholder to transfer a share is one of the rights attached to that property. A company’s articles should not be construed so as to cut down that right unless that is the fair interpretation of the articles.”
“A director of a company must – (a) act in accordance with the company’s constitution, and (b) only exercise powers for the purposes for which they are conferred.”
“A director of a company must act in the way he considers, in good faith, would be most likely to promote the success of the company for the benefit of its members as a whole, and in doing so have regard (amongst other matters) to— (a) the likely consequences of any decision in the long term, (b) the interests of the company's employees, (c) the need to foster the company's business relationships with suppliers, customers and others, (d) the impact of the company's operations on the community and the environment, (e) the desirability of the company maintaining a reputation for high standards of business conduct, and (f) the need to act fairly as between members of the company.” (a) act in accordance with the company’s constitution, and (b) only exercise powers for the purposes for which they are conferred.”
“bona fide in what they consider – not what a court may consider – is in the interests of the company.”
“… the power … must, like all other powers, be exercised subject to those principles of law and equity which are applicable to all powers conferred on majorities and enabling them to bind minorities. It must be exercised, not only in the manner required by law, but also bona fide for the benefit of the company as a whole, and it must not be exceeded.”
“Now when persons, honestly endeavouring to decide what will be for the benefit of the company and to act accordingly, decide upon a particular course, then, provided there are grounds on which reasonable men could come to the same decision, it does not matter whether the Court would or would not come to the same decision or a different decision. It is not the business of the Court to manage the affairs of the company. That is for the shareholders and directors. The absence of any reasonable ground for deciding that a certain course of action is conducive to the benefit of the company may be a ground for finding lack of good faith or for finding that the shareholders, with the best motives, have not considered the matters which they ought to have considered. On either of these findings their decision might be set aside. . .”
“. . . the same principle must apply when an amendment which the shareholders bona fide consider to be for the benefit of the company as a whole also operates to the particular advantage of some shareholders.”
“. . . tried to preserve the application of the traditional test by saying that in such cases “the company as a whole” did not mean the company as a corporate entity but ‘the corporators as a general body” and that it was necessary to ask whether the amendment was, in the honest opinion of those who voted in favour, for the benefit of a hypothetical member.”
“I have formed the view that the independent directors should not, as directors, hold themselves out as negotiating with Newco on the terms for recommendation to the shareholders. The normal considerations in a public takeover are not relevant here, and so the Company’s role (and so the role of the directors) should only be to ensure compliance with the various obligations to which it is subject. To the extent that the independent directors wish to enter into negotiations on terms, they should do so as shareholders. You will appreciate this is to ensure that neither the Company nor the directors (in that capacity) incur any liability to shareholders in relation to the terms of the acquisition.”
“ . . the petition plays, in my judgment, a vital role in defining the basis of the petitioner’s case. This is not a question of taking technical pleading points. The petition must be read sensibly. But it does mean that the grounds on which the petitioner says the affairs of the company have been conducted in an unfairly prejudicial manner should be fairly set out in the petition. Only in this way will the respondents be able properly to meet the case and the court be able to keep the proceedings within manageable bounds . . .”
“. . . the conduct relating to the making of the Offer and the attempt to expropriate Mr Arbuthnott’s shares which amounts to a single course of conduct, but one giving rise to various elements of unfair prejudice . . . relating both to the process surrounding the Offer and its content and then to the subsequent attempted expropriation after the Offer had been accepted. . . . .”
“I cannot accept the proposition that the board must inevitably be under a positive duty to recommend and take all steps within their power to facilitate whichever is the highest offer. In a case such as the present, where the directors proposed to exercise their undoubted right as shareholders to accept the lower offer in respect of their own shares and, for understandable and fully disclosed reasons, hope in their personal capacities that a majority of other shareholders will accept it as well, it seems to me that it would be artificial to say that they were under a positive duty to advise shareholders to accept the higher offer. The fact that they would get more money by taking the higher offer is hardly something which needs to be pointed out. I do not think that fairness can require more of the directors than to give the shareholders sufficient information and advice to enable them to reach a properly informed decision and to refrain from giving misleading advice or exercising their fiduciary powers in a way which would prevent or inhibit shareholders form choosing to take the better price. . . ”
“The starting point is the proposition that in general the right of a shareholder to vote his shares is a right of property which the shareholder is free to exercise in what he regards as his own best interests. He is not obliged to cast his vote in what others may regard as the best interests of the general body of shareholders, or in the best interests of the company as an entity in its own right.”
“As Charterhouse are in the business of valuing companies I cannot understand why the continuing shareholders have not already put their figure and terms on the table so that the non-conflicted shareholders can either say yes or no to it in principle…”
“KPMG did not really tell us anything that we, as experienced buyers and sellers of businesses, did not already know.”
“It is important to emphasise that all the uncertainties regarding the extent of the majority’s power to amend a company’s articles of association so as to introduce compulsory transfer provisions can be avoided by including these provisions in the company’s original articles at the time of its incorporation. It is clear that it will be very difficult for the minority to challenge the exercise [of] compulsory transfer provision if they are included in the company’s original articles. . ”
“Authority for the view that it is legitimate to exercise compulsory transfer provisions which are included in a company’s original articles is found in the decision of Court of Appeal in Albert Phillips and Albert Phillips Ltd v Manufactures’ Securities Ltd [(1917) 116 LT 290 ]. . . ”
“11. ALLOCATION OF PROFITS 11.1. The Managing Member shall take all decisions relating to the allocation of the profits of the LLP. 11.2. The Managing Member shall make determinations on all matters concerning the allocation of profits payable or proposed to be paid to any Member and any other matters relating to the benefits which may be enjoyed by Members (including, without limitation, Monthly Drawings Amounts, Special Drawings Amounts, the setting of performance targets, new co-investment opportunities and new entitlement to carried interests) and shall be empowered, on behalf of the LLP (but not on behalf of the relevant Member) to amend any of the terms upon which the relevant Member(s) provide services to the LLP from time to time (provided that, without prejudice to Clauses 17 and 18, any such amendment which is detrimental to the Member shall also require the approval of that Member). 11.3. Each of the parties hereto (with the exception of the LLP) hereby waives any right he may have to make a claim (whether in respect of any breach of fiduciary duties or otherwise) in respect of any allocation of profit share by the LLP to the Members (whether as part of a contractual right to be paid or as part of a discretionary element paid) provided the allocation of such profit share has been determined in accordance with Clauses 9.1 and these Clauses 11.1, 11.2 and 11.3. 11.4. Subject to Cause 12.7, each of the parties hereto agrees, and each of the parties (other than the LLP) undertakes to procure that so far as lawful and subject to: (a) making prudent provision for the continued operation of the business of the LLP (including the allocation of profits referred to in Clauses 11.1, 11.2 and 11.3 above); and (b) the LLP having sufficient funds available for such purpose (and not requiring to incur any further borrowings), all profits available to the LLP in respect of each financial year shall be allocated amongst and paid to the Members forthwith upon the audited accounts of the LLP being duly signed by the Designated Members for the relevant year.” (a) making prudent provision for the continued operation of the business of the LLP (including the allocation of profits referred to in Clauses 11.1, 11.2 and 11.3 above); and (b) the LLP having sufficient funds available for such purpose (and not requiring to incur any further borrowings), all profits available to the LLP in respect of each financial year shall be allocated amongst and paid to the Members forthwith upon the audited accounts of the LLP being duly signed by the Designated Members for the relevant year.”
“ . . . .it may perhaps be that the consideration by the directors of whether a dividend should be declared was not as anxious as it might have been, but the answer to the question of whether any dividend should be declared would have been no different had more detailed consideration been given, as the answer was obvious. [142] Finally on this point, I would not in the circumstances of this case have upheld a complaint of failure to pay dividends in circumstances where the growth policy was adopted and acquiesced in at a time when Ms Kohli was a director. In that respect, the normal expectation of shareholders was abrogated or qualified.”
“The parties hereto shall procure, so far as they are able, that such determinations are implemented by the LLP and any member of the Group which is Member of the LLP.”